Zhejiang Paradise
VC Fund
Hangzhou, China
Zhejiang Paradise is a VC fund in Hangzhou focused on Manufacturing and Medical. Zhejiang Silicon Paradise Asset Management Group (“TTGG” or “Company”) was founded on Nov. 11, 2000. It has become one of the largest private equity companies in China, No. 1 in Zhejiang Province. Currently, the Company has registered capital of RMB1.2bn, and its shareholders include Heaven-Sent Capital Management Group, Qianjiang Water ResourcesDevelopment Co., Ltd., Zhejiang Orient Holdings Co., Ltd., Minfeng Special Paper Co., Ltd., Chint Group, and Zhejiang Research Institute of Chemical Industry.
- Total investments:
- 89
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Zhejiang Paradise invests in
Stages Zhejiang Paradise invests in
Countries Zhejiang Paradise invests in
Investment Focus
Industry
- Manufacturing 28 (31%)
- Medical 8 (9%)
- Health Care 7 (8%)
- Information Technology 7 (8%)
- Software 6 (7%)
Stage
- Funding Round 33 (37%)
- Series B 15 (17%)
- Series A 8 (9%)
- Post-IPO Equity 8 (9%)
- Angel 7 (8%)
Country
- China 75 (84%)
- Hong Kong 2 (2%)
- United States 2 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Squirrel Power
|
Squirrel Power is an emerging Chinese electric vehicle brand that is rapidly gaining attention for its innovative designs, sustainable technologies, and commitment to making electric mobility more accessible to a wider range of consumers. | Series A / Aug 06, 2026 | |
Evotrex
|
Evotrex focused on changing outdoor travel and adventure by introducing clever, power-generating RV trailers geared for self-sufficiency and off-grid exploration. | $30M / Series A / Jun 09, 2026 | |
Wolai New Materials
|
Wolai New Materials is a high-tech enterprise specializing in the research and development of advanced composite materials, dedicated to innovating cutting-edge solutions that enhance material performance, improve manufacturing efficiency, and support applications across various industries such as aerospace, automotive, construction, and energy. | Venture - Series Unknown / Nov 24, 2025 | |
Polly Polymer
|
Polly Polymer is a manufacturer of 3D printing terminals. They are engaged in the research and development of dental and medical polymer materials and 3D printing for sports equipment, medical devices, consumer electronics, automobiles, and other industries, enabling clients to shorten the research and development cycle and reduce costs. PollyPolymer, with its superior materials and large-scale 3D printing production, has become a catalyst for corporate digital intelligent manufacturing transformation, upgrading, and innovation. | Series B / Nov 13, 2025 | |
|
Jinggou Biotech
|
Jinggou Biotech is a technology-driven company that focuses on synthetic biology research and development. | Seed / Aug 20, 2025 | |
Suzhou Meichuang
|
Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance | $27.8M / Series B / Jun 13, 2025 | |
Newmut Nanotechnology
|
Newmut Nano is a company with advanced technology in the domains of vapor deposition and high-temperature treatment reaction equipment both domestically and internationally. The principal products are experimental-grade and mass-production-grade fluidized bed reactors (FB-CVD), which are primarily employed in the manufacturing of carbon nanotubepowder and the CVD coating of silicon-based anodes for lithium batteries. | Series B / Apr 07, 2025 | |
|
Xinshengji Intelligence
|
Xinshengji Intelligence is a high-tech company that combines R&D, design, manufacturing, and sales of commercial service robots. | Seed / Sep 06, 2024 | |
Geyuan New Materials
|
Geyuan New Materials develops high-performance silicon-based anode materials. The company is committed to the large-scale development and manufacturing of high-performance silicon-based anode materials, with a focus on the industrialization of porous carbon, vapor deposition equipment, and new silicon-carbon anode materials. | Seed / Sep 02, 2024 | |
Xinzeyuan Medical
|
Xinzeyuan Medical is a manufacturer of key precision components and medical endoscope consumables. | $14.3M / Series B / Jul 08, 2024 | |
| See all 89 investments → | |||
Co-Investors
Zhejiang Silicon Paradise Asset Management Group
5 deals together
Haibang Capital
3 deals together
HSG
3 deals together
HSG
3 deals together
GSR United Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Zhejiang Paradise invest in?
Zhejiang Paradise invests primarily in Manufacturing, Medical and Health Care startups, most often at Funding Round and Series B stage. Most of the 89 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Zhejiang Paradise last invest?
The most recent investment recorded for Zhejiang Paradise closed in Aug 2026. Shizune tracks 89 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
